Postprandial reduction in high-density lipoprotein cholesterol concentrations in postmenopausal women: Improvement by 17β-estradiol

Metabolism: Clinical and Experimental

Volumn 45, Issue 7, 1996, Pages 827-832

  Westerveld, H Tineke ^a   Meijer, Ellen ^a   Erkelens, D Willem ^a   De Bruin, Tjerk W A ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; ESTRADIOL; ESTROFEM; ESTRONE; FOLLITROPIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; RETINOL; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROGENESIS; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY RISK; ESTROGEN THERAPY; FAT INTAKE; FEMALE; HORMONE SUBSTITUTION; HUMAN; LIPID METABOLISM; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; PRIORITY JOURNAL;

EID: 0030001260     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90154-7     Document Type: Article

References (28)

1. Bush TL, Fried LP, Barrett-Connor E: Cholesterol, lipoproteins, and coronary heart disease in women. Clin Chem 34:B60-B70, 1988
2. Bass KM, Newschaeffer CJ, Klag MJ, et al: Plasma lipoprotein levels as predictors of cardiovascular disease in women. Arch Intern Med 153:2209-2216, 1993
3. Brinton EA, Eisenberg S, Breslow J: Human HDL cholesterol levels are determined by apo A-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Arterioscler Thromb 14:707-720, 1994
4. Schaefer EJ, Lamon-Fava S, Ordovas JM, et al: Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham Offspring Study. J Lipid Res 35:871-882, 1994
5. Matthews KA, Meilahn E, Kuller LH, et al: Menopause and risk factors for coronary heart disease. N Engl J Med 321:641-646, 1989
6. Williams PT, Vranizan KM, Austin MA, et al: Associations of age, adiposity, alcohol intake, menstrual status, and estrogen therapy with high-density lipoprotein subclasses. Arterioscler Thromb 13:1654-1661, 1993
7. Walsh BW, Li H, Sacks FM: Effects of postmenopausal hormone replacement therapy with oral and transdermal estrogen on high density lipoprotein metabolism. J Lipid Res 35:2083-2093, 1994
8. Barter P: High-density lipoproteins and reverse cholesterol transport. Curr Opin Lipidol 4:210-217, 1993
9. Mackness MI, Abbott C, Arrol S, et al: The role of high density lipoprotein and lipid soluble anti oxidant vitamins in inhibiting low density lipoprotein oxidation. Biochem J 294:829-834, 1993
10. Chung BH, Segrest JP, Smith K, et al: Lipolytic surface remnants of triglyceride-rich lipoproteins are cytotoxic to macrophages but not in the presence of high density lipoprotein. J Clin Invest 83:1363-1374, 1989
11. Karpe F, Bard J-M, Steiner G, et al: HDLs and alimentary lipemia. Studies in men with previous myocardial infarction at a young age. Arterioscler Thromb 13:11-22, 1993
12. O'Meara NM, Lewis GF, Cabana VG, et al: Role of basal triglyceride and high density lipoprotein in determination of postprandial lipid and lipoprotein responses. J Clin Endocrinol Metab 75:465-471, 1992
13. Bruin TWA de, Brouwer CB, Gimpel JA, et al: Postprandial decrease in HDL-cholesterol and HDL-associated apo A-I in normal subjects in relation to TG metabolism. Am J Physiol 260:E492-E498, 1991
14. Fielding CJ, Fielding PE: Molecular physiology of reverse cholesterol transport. J Lipid Res 36:211-228, 1995
15. Cohn JS, McNamara JR, Cohn SD, et al: Postprandial plasma lipoprotein changes in human subjects of different ages. J Lipid Res 29:469-479, 1988
16. Patsch JR, Prasad S, Gotto AM Jr, et al: Postprandial lipemia. A key for the conversion of high density lipoprotein2 into high density lipoprotein3 by hepatic lipase. J Clin Invest 74:2017-2023, 1984
17. Patsch JS, Miesenböck G, Hopferwieser T, et al: Relation of triglyceride metabolism and coronary artery disease. Arterioscler Thromb 12:1336-1345, 1992
18. Castro Cabezas M, de Bruin TWA, Janssen H, et al: Impaired chylomicron remnant clearance in familial combined hyperlipidemia. Arterioscler Thromb 13:804-814, 1993
19. Reitsma JB, Castro Cabezas M, de Bruin TWA, et al: Relationship between improved postprandial lipemia and low-density lipoprotein metabolism during treatment with tetrahydrolipstatin, a pancreas lipase inhibitor. Metabolism 43:293-298, 1994
20. Hüttünen JK, Ehnholm C, Kinnunen PKJ, et al: An immunochemical method for the selective measurement of two triglyceride lipases in human postheparin plasma. Clin Chim Acta 63:335-347, 1975
21. National Institutes of Health Consensus Conference: Triglyceride, high-density lipoprotein, and coronary heart disease. JAMA 269:505-510, 1993
22. Westerveld HE, Kock LAW, Rijn HJM van, et al: 17β-Estradiol improves postprandial lipid metabolism in postmenopausal women. J Clin Endocrinol Metab 80:249-253, 1995
23. Stampfer MJ, Colditz GA, Willett WC, et al: Postmenopausal estrogen therapy and cardiovascular disease. N Engl J Med 325:756-762, 1991
24. Assmann G, Schulte H: Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease. Am J Cardiol 70:733-737, 1992
25. Manninen V, Tenkanen L, Koskinen P, et al: Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Circulation 85:37-45, 1992
26. Colvin PL, Auerbach BJ, Case LD, et al: A dose-response relationship between sex hormone induced change in hepatic triglyceride lipase and high density lipoprotein cholesterol in postmenopausal women. Metabolism 10:1052-1056, 1991
27. Walsh BW, Schiff I, Rosner B, et al: Effects of postmenopausal estrogen replacement therapy on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 325:1196-1204, 1991
28. Eisenberg S: High density lipoprotein metabolism. J Lipid Res 25:1017-1058, 1984